Citigroup Inc Roivant Sciences Ltd. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Citigroup Inc holds 296,766 shares of ROIV stock, worth $3.72 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

296,766

Previous 151,036 96.49%

Holding current value

$3.72 Million

Previous $1.6 Million 114.54%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$10.17 - $12.5 $1.48 Million - $1.82 Million	145,730 Added 96.49%	296,766 $3.42 Million
Q2 2024 Aug 12, 2024	SELL	$10.36 - $11.74 $7.23 Million - $8.19 Million	-698,009 Reduced 82.21%	151,036 $1.6 Million
Q1 2024 May 10, 2024	BUY	$9.87 - $11.8 $4.75 Million - $5.68 Million	481,139 Added 130.78%	849,045 $8.95 Million
Q4 2023 Feb 09, 2024	BUY	$8.38 - $11.58 $347,560 - $480,280	41,475 Added 12.71%	367,906 $4.13 Million
Q3 2023 Nov 09, 2023	BUY	$9.76 - $13.19 $998,243 - $1.35 Million	102,279 Added 45.63%	326,431 $3.81 Million
Q2 2023 Aug 10, 2023	SELL	$7.09 - $10.08 $2.75 Million - $3.92 Million	-388,424 Reduced 63.41%	224,152 $2.26 Million
Q1 2023 May 11, 2023	BUY	$6.92 - $9.98 $3.34 Million - $4.81 Million	482,220 Added 369.93%	612,576 $4.52 Million
Q4 2022 Feb 09, 2023	BUY	$3.36 - $7.99 $399,655 - $950,370	118,945 Added 1042.37%	130,356 $1.04 Million
Q3 2022 Nov 10, 2022	SELL	$0.51 - $4.84 $4,865 - $46,178	-9,541 Reduced 45.54%	11,411 $37,000
Q2 2022 Aug 10, 2022	BUY	$2.81 - $4.84 $42,720 - $73,582	15,203 Added 264.45%	20,952 $85,000
Q1 2022 May 12, 2022	BUY	$4.74 - $9.91 $25,818 - $53,979	5,447 Added 1803.64%	5,749 $28,000
Q4 2021 Feb 10, 2022	BUY	$5.86 - $13.52 $1,769 - $4,083	302 New	302 $3,000

Others Institutions Holding ROIV

# of Institutions

311

Shares Held

508M

Call Options Held

1.26M

Put Options Held

2.52M

View Full List

About Roivant Sciences Ltd.

Ticker ROIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 704,382,976
Market Cap $8.83B
Description
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...

More about ROIV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account